2015GMK016572/(US): This is a literature case report derived from a scientific literature published by Cossey M, 
Hsu A, Seguias L received on 20-Apr-2015 pertaining to 8 year old male patient, who developed recurrent 
rash(RASH), while receiving trimethoprim/sulphamethoxazole and paracetamol for an unknown indication. 
Citation: Cossey M, Hsu A, Seguias L. 8-Year-old boy with recurrent rash. Pediatrics in Review. 2015; 36(4): (pp 
e11-e13).
Concomitant medication and current condition of the patient was unknown at the time of report.
Patient started with trimethoprim/sulphamethoxazole and paracetamol (dose, frequency and route of administration 
Print Time: 15-JUL-2016 02:35 PM If a field is blank, there is no data for that field Page 356 of 517
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
unknown) for unknown indication. On an unknown date, patient developed recurrent rash. Action taken with the 
drug and outcome of the event was unknown at the time of report.
Author's discussion: Author discussed that; trimethoprim/sulphamethoxazole and paracetamol are commonly 
implicated in causing fixed drug eruptions. The mainstay of treatment is to prevent recurrence of the eruption by 
avoiding the offending drug.
The manufacturer of trimethoprim/sulphamethoxazole was unknown; however, Glenmark product cannot be ruled 
out as suspect.
This report is for a non-Glenmark product; hence is processed only for signal management. It is closed after data 
entry.